Tracking patient consent for the use of their samples in clinical trials is essential to both minimize risk of non-compliance and maximizing potential for future use.
In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, explains informed consent for patient samples and the importance of easily tracking consent as samples move through the clinical trial ecosystem.
She describes:
- How consent is or has been documented
- The benefits of electronic consent documentation
- Specific consent attributes, e.g. genetic testing
- Handling consent requirements from different countries or institutions
- Understanding consent for future use, including limitations and expirations
Learn more at https://www.q2labsolutions.com/labmatrix
Laboratory Considerations for Clinical Trials näytetään tässä palvelussa avoimen RSS-syötteen kautta. RSS-syötteen tiedostot, kuvaukset, kansikuvat ja muu metadata ovat podcastin omistajan omaisuutta, eivätkä ole yhteydessä Podplayn kanssa.